European journal of anaesthesiology · 2014
Effect of levobupivacaine on articular chondrocytes: an in-vitro investigation.
СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cobo-Molinos Jesús, Poncela-Garcia Mercedes, Marchal-Corrales Juan A, Delgado-Martinez Alberto D
Аннотация
BACKGROUND: Intra-articular injection of local anaesthetics is a technique commonly used to enhance postoperative analgesia following arthroscopic surgery. However, the potential for cartilage damage due to toxicity of intra-articular local anaesthetics is a concern. Most studies indicate that the toxic effect is drug and time dependent.
OBJECTIVES: The objective of this study is to compare the in-vitro chondrotoxic effect of levobupivacaine on human cartilage with saline and bupivacaine.
DESIGN: An experimental study.
SETTING: University hospital.
PARTICIPANTS: Adult patients undergoing knee surgery.
INTERVENTIONS: Human articular cartilage was harvested and removed from five patients during knee replacement surgery. Chondrocytes were cultured and divided into three groups exposed to bupivacaine 0.5%, levobupivacaine 0.5% or physiological saline for 15, 30 or 60 min.
MAIN OUTCOME MEASURES: Viability of human cartilage cells after contact with the different study drugs at different durations of exposure using two techniques: live/dead cell viability flow cytometry analysis and trypan blue exclusion assay.
RESULTS: At 1 h of exposure, chondrocyte mortality in cartilage explants was significantly greater after treatment with levobupivacaine or bupivacaine than with saline (25.9% ± 14.1, 20.7% ± 10.4 and 9.6% ± 5.4, respectively). No differences between groups were found when exposure to the experimental drug was limited to 15 or 30 min.
CONCLUSION: In-vitro 0.5% levobupivacaine is more chondrotoxic than saline in human articular cartilage after 1 h of exposure. Bupivacaine seems to be less chondrotoxic than levobupivacaine. With shorter exposures, no clear chondrotoxic effect was shown.
OBJECTIVES: The objective of this study is to compare the in-vitro chondrotoxic effect of levobupivacaine on human cartilage with saline and bupivacaine.
DESIGN: An experimental study.
SETTING: University hospital.
PARTICIPANTS: Adult patients undergoing knee surgery.
INTERVENTIONS: Human articular cartilage was harvested and removed from five patients during knee replacement surgery. Chondrocytes were cultured and divided into three groups exposed to bupivacaine 0.5%, levobupivacaine 0.5% or physiological saline for 15, 30 or 60 min.
MAIN OUTCOME MEASURES: Viability of human cartilage cells after contact with the different study drugs at different durations of exposure using two techniques: live/dead cell viability flow cytometry analysis and trypan blue exclusion assay.
RESULTS: At 1 h of exposure, chondrocyte mortality in cartilage explants was significantly greater after treatment with levobupivacaine or bupivacaine than with saline (25.9% ± 14.1, 20.7% ± 10.4 and 9.6% ± 5.4, respectively). No differences between groups were found when exposure to the experimental drug was limited to 15 or 30 min.
CONCLUSION: In-vitro 0.5% levobupivacaine is more chondrotoxic than saline in human articular cartilage after 1 h of exposure. Bupivacaine seems to be less chondrotoxic than levobupivacaine. With shorter exposures, no clear chondrotoxic effect was shown.